Cross-source evidence timeline
Octreotide research timeline
Follow 157 selected, directly cited source records from October 21, 1988 through August 13, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Real-World Indirect Treatment Comparison of Terlipressin vs Midodrine Plus Octreotide in Hepatorenal Syndrome-Acute Kidney Injury.↗
PubMed lists PMID 41472624 in Clinical and translational gastroenterology as Journal Article, Comparative Study, with publication-date metadata of 2026-02-01 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 1, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Uptake of 18F-AlF-NOTA-octreotide PET/CT in gastrointestinal stromal tumors.↗
PubMed lists PMID 42026400 in EJNMMI reports as Journal Article, with publication-date metadata of 2026-04-24 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 24, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Transarterial embolization combined with octreotide long-acting release in treating rectal neuroendocrine tumor liver metastases: a single-institutional experience.↗
PubMed lists PMID 42169939 in Journal of gastrointestinal oncology as Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 28, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.↗
PubMed lists PMID 42370133 in Frontiers in oncology as Case Reports, Journal Article, with publication-date metadata of 2026-06-11 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 11, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
PubMed record PMID 39631560↗
PeptideScanner retained PubMed bibliographic metadata for PMID 39631560 at 2026-08-10T10:49:06.913Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2024-12-04. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 37951584↗
PeptideScanner retained PubMed bibliographic metadata for PMID 37951584 at 2026-08-10T10:49:06.851Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2023-11-11. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 38407358↗
PeptideScanner retained PubMed bibliographic metadata for PMID 38407358 at 2026-08-10T10:49:06.879Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2024-02-26. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 42029102↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42029102 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-04-24. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 42333429↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42333429 at 2026-08-10T10:49:10.713Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-23. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 42515664↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42515664 at 2026-08-10T10:49:12.892Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT00569127↗
PeptideScanner retained ClinicalTrials.gov record NCT00569127 at 2026-08-10T18:10:03.946Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 14, 2026Literature metadata
PubMed record PMID 41719493↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41719493 at 2026-08-10T18:13:42.706Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-02-20. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
Octreotide therapy in patients with a left ventricular assist device and bleeding gastrointestinal angiodysplasias.↗
PubMed lists PMID 40086695 in The American journal of the medical sciences as Journal Article, with publication-date metadata of 2025-03-12 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 12, 2025 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
SSTR-Mediated Precision Delivery: Overcoming Triptolide's Limitations through Octreotide Conjugation in Pancreatic Cancer Treatment.↗
PubMed lists PMID 40529047 in ACS medicinal chemistry letters as Journal Article, with publication-date metadata of 2025-05-13 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 13, 2025 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Optimization of automated radiosynthesis method for [18F]AlF-NOTA-Octreotide and PET/CT imaging in neuroendocrine neoplasms.↗
PubMed lists PMID 42014536 in EJNMMI radiopharmacy and chemistry as Journal Article, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 21, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
PubMed record PMID 42503373↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42503373 at 2026-08-10T18:13:56.753Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-26. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
Octreotide in the Management of Chyle Leaks After Head and Neck Surgery: A Systematic Review of Cohort Studies.↗
PubMed lists PMID 42478204 in The Journal of laryngology and otology as Journal Article, Review, with publication-date metadata of 2026-07-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 21, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis.↗
PubMed lists PMID 41647114 in Frontiers in endocrinology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2026-01-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 21, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Latent phosphaturic mesenchymal tumor in left planta detected by [18F]F-AlF-NOTA-octreotide PET/CT.↗
PubMed lists PMID 38568449 in European journal of nuclear medicine and molecular imaging as Case Reports, Journal Article, with publication-date metadata of 2024-04-03 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 3, 2024 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Comprehensive design and characterization of pH-gradient-loaded donkey-milk exosomes for oral octreotide delivery: A bench-to-in silico roadmap.↗
PubMed lists PMID 41831704 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 12, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Recurrent ventricular asystole during octreotide infusion in a patient with pancreatic neuroendocrine tumor: a case report.↗
PubMed lists PMID 41840662 in Journal of medical case reports as Journal Article, Case Reports, with publication-date metadata of 2026-03-16 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 16, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].↗
PubMed lists PMID 17922063 in Magyar onkologia as Journal Article, with publication-date metadata of 2007-10-07 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 7, 2007 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Octreotide and Octreotide-derived delivery systems.↗
PubMed lists PMID 37211679 in Journal of drug targeting as Journal Article, Review, with publication-date metadata of 2023-05-23 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 23, 2023 · day precisionAdded to PeptideScanner August 16, 2026Safety
FDA enforcement report D-0519-2026↗
FDA's dated enforcement report D-0519-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026Safety
FDA enforcement report D-0404-2026↗
FDA's dated enforcement report D-0404-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026Safety
FDA enforcement report D-0405-2026↗
FDA's dated enforcement report D-0405-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026Safety
FDA enforcement report D-0406-2026↗
FDA's dated enforcement report D-0406-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026Clinical trials
ClinicalTrials.gov record NCT07460908↗
PeptideScanner retained ClinicalTrials.gov record NCT07460908 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 8, 2026Regulatory
Federal Register notice 2026-03963↗
The Federal Register published notice 2026-03963, attributed to FDA and its parent HHS department, on 2026-02-27. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide and Semaglutide.↗
Added to PeptideScanner August 21, 2026Clinical trials
ClinicalTrials.gov record NCT03879694↗
PeptideScanner retained ClinicalTrials.gov record NCT03879694 at 2026-07-30T16:23:45.670Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 8, 2026Regulatory
Octreotide DailyMed SPL version 2↗
DailyMed lists Structured Product Labeling version 2 for the reviewed Octreotide label family with a published date of 2026-02-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2025
Clinical trials
ClinicalTrials.gov record NCT07262957↗
PeptideScanner retained ClinicalTrials.gov record NCT07262957 at 2026-07-30T18:18:33.513Z. Its registry update date was 2025-12-22, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Drugs@FDA application ANDA216589↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 216589 with status AP dated 2025-12-12, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT00262470↗
PeptideScanner retained ClinicalTrials.gov record NCT00262470 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-08, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT03000946↗
PeptideScanner retained ClinicalTrials.gov record NCT03000946 at 2026-07-30T18:22:04.914Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT06193616↗
PeptideScanner retained ClinicalTrials.gov record NCT06193616 at 2026-07-30T18:22:04.914Z. Its registry update date was 2025-09-05, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT06974344↗
PeptideScanner retained ClinicalTrials.gov record NCT06974344 at 2026-07-30T18:27:14.162Z. Its registry update date was 2025-05-15, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT03289741↗
PeptideScanner retained ClinicalTrials.gov record NCT03289741 at 2026-07-30T18:27:14.159Z. Its registry update date was 2025-05-09, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 13, 2026Clinical trials
ClinicalTrials.gov record NCT02457156↗
PeptideScanner retained ClinicalTrials.gov record NCT02457156 at 2026-07-30T18:30:10.981Z. Its registry update date was 2025-03-13, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00463983↗
PeptideScanner retained ClinicalTrials.gov record NCT00463983 at 2026-07-30T18:30:10.977Z. Its registry update date was 2025-03-05, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2024
Regulatory
Drugs@FDA application NDA213224↗
The official Drugs@FDA dataset lists original submission 1 for NDA 213224 with status AP dated 2024-09-27, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA217860↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 217860 with status AP dated 2024-05-02, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
2023
Regulatory
Drugs@FDA application ANDA210317↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 210317 with status AP dated 2023-12-05, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Octreotide DailyMed SPL version 1↗
DailyMed lists Structured Product Labeling version 1 for the reviewed Octreotide label family with a published date of 2023-12-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Clinical trials
ClinicalTrials.gov record NCT02381249↗
PeptideScanner retained ClinicalTrials.gov record NCT02381249 at 2026-07-30T19:04:52.219Z. Its registry update date was 2023-11-27, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02385617↗
PeptideScanner retained ClinicalTrials.gov record NCT02385617 at 2026-07-30T19:04:52.214Z. Its registry update date was 2023-11-27, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00427349↗
PeptideScanner retained ClinicalTrials.gov record NCT00427349 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-05, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA216839↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 216839 with status AP dated 2023-06-22, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT00003057↗
PeptideScanner retained ClinicalTrials.gov record NCT00003057 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-18, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00003283↗
PeptideScanner retained ClinicalTrials.gov record NCT00003283 at 2026-07-30T19:11:49.727Z. Its registry update date was 2023-06-15, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Drugs@FDA application ANDA216807↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 216807 with status AP dated 2023-06-13, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT02333565↗
PeptideScanner retained ClinicalTrials.gov record NCT02333565 at 2026-07-30T19:13:03.754Z. Its registry update date was 2023-05-25, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02384122↗
PeptideScanner retained ClinicalTrials.gov record NCT02384122 at 2026-07-30T19:13:03.754Z. Its registry update date was 2023-05-24, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2022
Safety
FDA enforcement report D-0058-2023↗
FDA's dated enforcement report D-0058-2023 lists Class I and source status Terminated for Viatris Inc. PeptideScanner connects the report to reviewed application ANDA079198 through exact openFDA application-number annotations.↗
Added to PeptideScanner August 25, 2026Clinical trials
ClinicalTrials.gov record NCT01229943↗
PeptideScanner retained ClinicalTrials.gov record NCT01229943 at 2026-07-30T19:36:31.409Z. Its registry update date was 2022-08-04, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02010385↗
PeptideScanner retained ClinicalTrials.gov record NCT02010385 at 2026-07-30T19:39:59.677Z. Its registry update date was 2022-05-23, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT03520569↗
PeptideScanner retained ClinicalTrials.gov record NCT03520569 at 2026-07-30T19:39:59.677Z. Its registry update date was 2022-05-13, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2021
Clinical trials
ClinicalTrials.gov record NCT03734627↗
PeptideScanner retained ClinicalTrials.gov record NCT03734627 at 2026-07-30T19:59:58.328Z. Its registry update date was 2021-08-16, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Federal Register notice 2021-11575↗
The Federal Register published notice 2021-11575, attributed to FDA and its parent HHS department, on 2021-06-02. Its official title is “Determination That SANDOSTATIN (Octreotide Acetate) Injection, Equal to 0.2 Milligrams Base/Milliliter and Equal to 1 Milligrams Base/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.↗
Added to PeptideScanner August 21, 2026Regulatory
Federal Register notice 2021-06202↗
The Federal Register published notice 2021-06202, attributed to FDA and its parent HHS department, on 2021-03-25. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide and Octreotide.↗
Added to PeptideScanner August 21, 2026
Source year
2020
Clinical trials
ClinicalTrials.gov record NCT02916433↗
PeptideScanner retained ClinicalTrials.gov record NCT02916433 at 2026-07-30T20:21:17.072Z. Its registry update date was 2020-10-08, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT04129255↗
PeptideScanner retained ClinicalTrials.gov record NCT04129255 at 2026-07-30T20:22:36.942Z. Its registry update date was 2020-09-10, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Drugs@FDA application NDA208232↗
The official Drugs@FDA dataset lists original submission 1 for NDA 208232 with status AP dated 2020-06-26, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT00002864↗
PeptideScanner retained ClinicalTrials.gov record NCT00002864 at 2026-07-30T20:29:13.581Z. Its registry update date was 2020-04-01, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT04281680↗
PeptideScanner retained ClinicalTrials.gov record NCT04281680 at 2026-07-30T20:32:04.760Z. Its registry update date was 2020-02-24, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00226967↗
PeptideScanner retained ClinicalTrials.gov record NCT00226967 at 2026-07-30T20:33:20.622Z. Its registry update date was 2020-01-27, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2019
Clinical trials
ClinicalTrials.gov record NCT01865760↗
PeptideScanner retained ClinicalTrials.gov record NCT01865760 at 2026-07-30T20:44:36.695Z. Its registry update date was 2019-10-28, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT03846180↗
PeptideScanner retained ClinicalTrials.gov record NCT03846180 at 2026-07-30T20:48:52.443Z. Its registry update date was 2019-07-05, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2018
Regulatory
Drugs@FDA application ANDA204669↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 204669 with status AP dated 2018-12-27, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA203765↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 203765 with status AP dated 2018-09-07, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT00966355↗
PeptideScanner retained ClinicalTrials.gov record NCT00966355 at 2026-07-30T21:12:47.407Z. Its registry update date was 2018-03-19, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2017
Regulatory
Federal Register notice 2017-25920↗
The Federal Register published notice 2017-25920, attributed to FDA and its parent HHS department, on 2017-12-01. Its official title is “Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.↗
Added to PeptideScanner August 21, 2026Clinical trials
ClinicalTrials.gov record NCT03061604↗
PeptideScanner retained ClinicalTrials.gov record NCT03061604 at 2026-07-30T21:22:00.250Z. Its registry update date was 2017-11-14, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02474914↗
PeptideScanner retained ClinicalTrials.gov record NCT02474914 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-08-22, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00600886↗
PeptideScanner retained ClinicalTrials.gov record NCT00600886 at 2026-07-30T21:23:14.761Z. Its registry update date was 2017-07-02, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Federal Register notice 2017-12908↗
The Federal Register published notice 2017-12908, attributed to FDA and its parent HHS department, on 2017-06-21. Its official title is “Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.↗
Added to PeptideScanner August 21, 2026Clinical trials
ClinicalTrials.gov record NCT00182754↗
PeptideScanner retained ClinicalTrials.gov record NCT00182754 at 2026-07-30T21:24:24.234Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00332969↗
PeptideScanner retained ClinicalTrials.gov record NCT00332969 at 2026-07-30T21:25:36.783Z. Its registry update date was 2017-03-31, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00171886↗
PeptideScanner retained ClinicalTrials.gov record NCT00171886 at 2026-07-30T21:25:36.764Z. Its registry update date was 2017-02-24, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00223691↗
PeptideScanner retained ClinicalTrials.gov record NCT00223691 at 2026-07-30T21:25:36.812Z. Its registry update date was 2017-01-18, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2016
Clinical trials
ClinicalTrials.gov record NCT00002779↗
PeptideScanner retained ClinicalTrials.gov record NCT00002779 at 2026-07-30T21:34:56.506Z. Its registry update date was 2016-12-15, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01204476↗
PeptideScanner retained ClinicalTrials.gov record NCT01204476 at 2026-07-30T21:36:16.909Z. Its registry update date was 2016-07-15, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00033605↗
PeptideScanner retained ClinicalTrials.gov record NCT00033605 at 2026-07-30T21:36:16.907Z. Its registry update date was 2016-07-13, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00241020↗
PeptideScanner retained ClinicalTrials.gov record NCT00241020 at 2026-07-30T21:37:20.823Z. Its registry update date was 2016-04-12, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01121939↗
PeptideScanner retained ClinicalTrials.gov record NCT01121939 at 2026-07-30T21:38:42.856Z. Its registry update date was 2016-02-05, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2015
Clinical trials
ClinicalTrials.gov record NCT01917773↗
PeptideScanner retained ClinicalTrials.gov record NCT01917773 at 2026-07-30T21:39:57.679Z. Its registry update date was 2015-12-21, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2014
Clinical trials
ClinicalTrials.gov record NCT02305069↗
PeptideScanner retained ClinicalTrials.gov record NCT02305069 at 2026-07-30T21:54:46.552Z. Its registry update date was 2014-12-02, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00412061↗
PeptideScanner retained ClinicalTrials.gov record NCT00412061 at 2026-07-30T21:54:46.554Z. Its registry update date was 2014-11-21, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00521300↗
PeptideScanner retained ClinicalTrials.gov record NCT00521300 at 2026-07-30T21:54:46.544Z. Its registry update date was 2014-06-02, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Federal Register notice 2014-07330↗
The Federal Register published notice 2014-07330, attributed to FDA and its parent HHS department, on 2014-04-02. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.↗
Added to PeptideScanner August 21, 2026
Source year
2013
Clinical trials
ClinicalTrials.gov record NCT00008073↗
PeptideScanner retained ClinicalTrials.gov record NCT00008073 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-12-19, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Literature metadata
The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids.↗
PubMed lists PMID 2045464 in The Journal of clinical endocrinology and metabolism as Journal Article, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1991-07 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 1991 · month precisionAdded to PeptideScanner August 16, 2026Literature metadata
[Modification of the motility of stomach, intestine and gallbladder by octreotide].↗
PubMed lists PMID 1980772 in Zeitschrift fur Gastroenterologie as Journal Article, with publication-date metadata of 1990-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 1990 · month precisionAdded to PeptideScanner August 14, 2026Literature metadata
[Clinical applications of octreotide in gastro-entero-pancreatic (GEP) tumors].↗
PubMed lists PMID 1980774 in Zeitschrift fur Gastroenterologie as Journal Article, Review, with publication-date metadata of 1990-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 1990 · month precisionAdded to PeptideScanner August 14, 2026Literature metadata
[Treatment of pseudocyst in chronic pancreatitis by puncture-drainage and octreotide combination].↗
PubMed lists PMID 1397864 in Gastroenterologie clinique et biologique as Case Reports, Letter, with publication-date metadata of 1992 (year precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 1992 · year precisionAdded to PeptideScanner August 13, 2026Literature metadata
Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.↗
PubMed lists PMID 1519586 in The American journal of gastroenterology as Case Reports, Journal Article, with publication-date metadata of 1992-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 1992 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Octreotide and vascular headache].↗
PubMed lists PMID 1523600 in Therapie as Letter, with publication-date metadata of 1992 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 1992 Jan-Feb · source-text precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Possible use of octreotide in gastrointestinal pathology and in diabetes mellitus].↗
PubMed lists PMID 1603422 in Minerva chirurgica as Journal Article, Review, with publication-date metadata of 1992-04-30 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 30, 1992 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Insulinoma and octreotide].↗
PubMed lists PMID 1614574 in Nederlands tijdschrift voor geneeskunde as Comment, Letter, with publication-date metadata of 1992-06-20 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 20, 1992 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
A randomized comparison of intranasal and injectable octreotide administration in patients with acromegaly.↗
PubMed lists PMID 1619006 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1992-07 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 1992 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Octreotide: clinical experience].↗
PubMed lists PMID 1620938 in Revista clinica espanola as Journal Article, Review, with publication-date metadata of 1992-05 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 1992 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly.↗
PubMed lists PMID 1631261 in The Quarterly journal of medicine as Journal Article, with publication-date metadata of 1992-04 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 1992 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Octreotide in intestinal pseudo-obstruction?].↗
PubMed lists PMID 1632118 in Zeitschrift fur Gastroenterologie as Journal Article, with publication-date metadata of 1992-05 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 1992 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.↗
PubMed lists PMID 1687076 in The Netherlands journal of medicine as Journal Article, Review, with publication-date metadata of 1991-12 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 1991 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.↗
PubMed lists PMID 1713038 in Acta oncologica (Stockholm, Sweden) as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 1991 (year precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 1991 · year precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Somatostatin and octreotide in therapy of gastrointestinal diseases].↗
PubMed lists PMID 1714136 in Zeitschrift fur Gastroenterologie. Verhandlungsband as Journal Article, Review, with publication-date metadata of 1991-03 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 1991 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Drug treatment of acute esophageal varices hemorrhage using vasoactive substances (somatostatin and octreotide)].↗
PubMed lists PMID 1980776 in Zeitschrift fur Gastroenterologie as Journal Article, Review, with publication-date metadata of 1990-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 1990 · month precisionAdded to PeptideScanner August 13, 2026Regulatory
Drugs@FDA application ANDA090834↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 090834 with status AP dated 2013-11-12, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA091041↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 091041 with status AP dated 2013-11-12, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Literature metadata
PubMed record PMID 23925288↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23925288 at 2026-07-30T21:57:02.018Z. PubMed recorded a metadata revision date of 2013-08-08 and an Entrez history date of 2013-08-09. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT00690430↗
PeptideScanner retained ClinicalTrials.gov record NCT00690430 at 2026-07-30T21:55:56.629Z. Its registry update date was 2013-07-30, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Literature metadata
PubMed record PMID 23789763↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23789763 at 2026-07-30T21:57:02.014Z. PubMed recorded a metadata revision date of 2013-06-24 and an Entrez history date of 2013-06-25. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 23780564↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23780564 at 2026-07-30T21:57:02.013Z. PubMed recorded a metadata revision date of 2013-06-21 and an Entrez history date of 2013-06-20. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 22874886↗
PeptideScanner retained PubMed bibliographic metadata for PMID 22874886 at 2026-07-30T21:57:01.388Z. PubMed recorded a metadata revision date of 2013-05-13 and an Entrez history date of 2012-08-10. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 23275042↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23275042 at 2026-07-30T21:57:01.399Z. PubMed recorded a metadata revision date of 2013-05-06 and an Entrez history date of 2013-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 23591434↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23591434 at 2026-07-30T21:57:01.412Z. PubMed recorded a metadata revision date of 2013-04-17 and an Entrez history date of 2013-04-18. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 23228417↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23228417 at 2026-07-30T21:57:01.397Z. PubMed recorded a metadata revision date of 2013-03-29 and an Entrez history date of 2012-12-12. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT01561066↗
PeptideScanner retained ClinicalTrials.gov record NCT01561066 at 2026-07-30T21:55:56.621Z. Its registry update date was 2013-02-26, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Literature metadata
PubMed record PMID 23140265↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23140265 at 2026-07-30T21:57:01.395Z. PubMed recorded a metadata revision date of 2013-01-01 and an Entrez history date of 2012-11-13. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026
Source year
2012
Clinical trials
ClinicalTrials.gov record NCT00426153↗
PeptideScanner retained ClinicalTrials.gov record NCT00426153 at 2026-07-30T22:14:20.912Z. Its registry update date was 2012-11-21, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00004895↗
PeptideScanner retained ClinicalTrials.gov record NCT00004895 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-06, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00171613↗
PeptideScanner retained ClinicalTrials.gov record NCT00171613 at 2026-07-30T22:14:20.909Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00257426↗
PeptideScanner retained ClinicalTrials.gov record NCT00257426 at 2026-07-30T22:14:20.913Z. Its registry update date was 2012-02-14, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Federal Register notice 2012-1433↗
The Federal Register published notice 2012-1433, attributed to FDA and its parent HHS department, on 2012-01-25. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.↗
Added to PeptideScanner August 21, 2026
Source year
2011
Regulatory
Drugs@FDA application ANDA090985↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 090985 with status AP dated 2011-05-11, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA090986↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 090986 with status AP dated 2011-05-11, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA079198↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 079198 with status AP dated 2011-02-10, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
2010
Clinical trials
ClinicalTrials.gov record NCT00005906↗
PeptideScanner retained ClinicalTrials.gov record NCT00005906 at 2026-07-30T22:25:23.111Z. Its registry update date was 2010-04-30, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026
Source year
2009
Literature metadata
PubMed record PMID 19864727↗
PeptideScanner retained PubMed bibliographic metadata for PMID 19864727 at 2026-07-30T22:27:39.979Z. PubMed recorded a metadata revision date of 2009-10-29 and an Entrez history date of 2009-10-30. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 19864763↗
PeptideScanner retained PubMed bibliographic metadata for PMID 19864763 at 2026-07-30T22:27:39.979Z. PubMed recorded a metadata revision date of 2009-10-29 and an Entrez history date of 2009-10-30. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 20641226↗
PeptideScanner retained PubMed bibliographic metadata for PMID 20641226 at 2026-07-30T22:27:39.988Z. PubMed recorded a metadata revision date of 2009-06-05 and an Entrez history date of 2009-06-05. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026
Source year
2008
Regulatory
Federal Register notice E8-24356↗
The Federal Register published notice E8-24356, attributed to FDA and its parent HHS department, on 2008-10-15. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.↗
Added to PeptideScanner August 21, 2026Regulatory
Drugs@FDA application ANDA077329↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077329 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA077330↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077330 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA077331↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077331 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
2007
Literature metadata
PubMed record PMID 17955038↗
PeptideScanner retained PubMed bibliographic metadata for PMID 17955038 at 2026-07-30T22:40:22.998Z. PubMed recorded a metadata revision date of 2007-12-17 and an Entrez history date of 2007-10-24. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT00534677↗
PeptideScanner retained ClinicalTrials.gov record NCT00534677 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-12-05, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Literature metadata
PubMed record PMID 20641749↗
PeptideScanner retained PubMed bibliographic metadata for PMID 20641749 at 2026-07-30T22:40:23.016Z. PubMed recorded a metadata revision date of 2007-11-07 and an Entrez history date of 2007-11-07. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Regulatory
Drugs@FDA application ANDA077372↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077372 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA077373↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077373 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Literature metadata
PubMed record PMID 15299336↗
PeptideScanner retained PubMed bibliographic metadata for PMID 15299336 at 2026-07-30T22:40:22.107Z. PubMed recorded a metadata revision date of 2007-07-24 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 15299335↗
PeptideScanner retained PubMed bibliographic metadata for PMID 15299335 at 2026-07-30T22:40:22.107Z. PubMed recorded a metadata revision date of 2007-07-24 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Regulatory
Federal Register notice E7-4877↗
The Federal Register published notice E7-4877, attributed to FDA and its parent HHS department, on 2007-03-19. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.↗
Added to PeptideScanner August 21, 2026Literature metadata
PubMed record PMID 17357189↗
PeptideScanner retained PubMed bibliographic metadata for PMID 17357189 at 2026-07-30T22:40:22.974Z. PubMed recorded a metadata revision date of 2007-03-14 and an Entrez history date of 2007-03-16. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 17335137↗
PeptideScanner retained PubMed bibliographic metadata for PMID 17335137 at 2026-07-30T22:40:22.973Z. PubMed recorded a metadata revision date of 2007-03-05 and an Entrez history date of 2007-03-06. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026
Source year
2006
Regulatory
Federal Register notice E6-17284↗
The Federal Register published notice E6-17284, attributed to FDA and its parent HHS department, on 2006-10-18. Its official title is “Summaries of Medical and Clinical Pharmacology Reviews of Pediatric Studies; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.↗
Added to PeptideScanner August 21, 2026Literature metadata
PubMed record PMID 16957757↗
PeptideScanner retained PubMed bibliographic metadata for PMID 16957757 at 2026-07-30T22:50:21.672Z. PubMed recorded a metadata revision date of 2006-09-07 and an Entrez history date of 2006-09-08. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Regulatory
Drugs@FDA application ANDA077450↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077450 with status AP dated 2006-02-10, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA077457↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 077457 with status AP dated 2006-02-10, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
2005
Regulatory
Drugs@FDA application ANDA075959↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 075959 with status AP dated 2005-11-21, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA075957↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 075957 with status AP dated 2005-10-03, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT00004327↗
PeptideScanner retained ClinicalTrials.gov record NCT00004327 at 2026-07-30T22:50:58.187Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was octreotide.↗
Added to PeptideScanner August 9, 2026Regulatory
Drugs@FDA application ANDA076330↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 076330 with status AP dated 2005-04-08, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA076313↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 076313 with status AP dated 2005-03-28, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
2004
Literature metadata
PubMed record PMID 8302723↗
PeptideScanner retained PubMed bibliographic metadata for PMID 8302723 at 2026-07-30T23:02:28.626Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1993-11-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026
Source year
1998
Regulatory
Drugs@FDA application NDA021008↗
The official Drugs@FDA dataset lists original submission 1 for NDA 021008 with status AP dated 1998-11-25, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
1988
Regulatory
Drugs@FDA application NDA019667↗
The official Drugs@FDA dataset lists original submission 1 for NDA 019667 with status AP dated 1988-10-21, and names octreotide acetate among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026